Edwards Lifesciences
Tracked across 4 events · 28 articles · First seen May 04, 2026 · Last active Sep 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Edwards Lifesciences announced positive 10-year results from its COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its RESILIA tissue, which is expected to positively impact its market position and growth.
May 04, 2026 · 6 articles
Business
Impact: Edwards Lifesciences organized and hosted the event, reinforcing its patient-focused culture and commitment to innovation in structural heart disease. The event may enhance its reputation and support long-term growth in the Asia Pacific market.
Jul 20, 2026 · 6 articles
Business
Impact: Edwards Lifesciences is mentioned as a previous employer of Davé, highlighting his background. No direct impact on Edwards from this event.
Sep 01, 2026 · 8 articles
Business
Impact: Edwards Lifesciences is mentioned as a previous employer of Tim Benner, providing context to his experience. No direct impact on the company.
Aug 03, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Edwards Lifesciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard